Related to China's Challenges Stretch Beyond the GSK Scandal

• Arrivederci, GINA
  New rules on protecting genetic privacy are under way, as study rekindles debate over sharing vs. protecting data.
  
• DNA Collection v. DNA Privacy
  Supreme Court weighs constitutionality of taking samples from arrested suspects absent a conviction.
  
• Stockholm-Uppsala Region Ups the Ante
  The region bets big in the quest for international renown.
  
• On the Menu: Supersized Soda Wars
  The NYC ruling halting the ban on large-sized sugary beverages is unlikely to stop future court fights over anti-obesity laws.
  
• GMO Rider: ‘Monsanto Protection’ or ‘Farmer Sustainability’?
  As Washington embraces GMOs, opponents look to studies, states, and retailers for support.
  
• Bird Flu Back Again?
  H7N9 has killed six people so far. Find out what’s being done about it.
  
• Poland Invests in Biotech Infrastructure
  Will it be enough for the industry to succeed?
  
• GEN Congressional Hall of Fame
  Biomedical research has friends in high places. Meet them.
  
• GEN Hall of Shame
  Meet the Congressional enemies of research funding.
  
• Across Pharma, Few Open Arms for Trial Data Sharing
  Industry inches toward consensus on limited sharing as EMA, GSK press for open access.
  
• Spreading Sunshine on What Biopharma Pays Physicians
  The new law requires more disclosure.
  
• Researchers Chafe as NIH Budgets Shrivel
  Many investigators affected by sequestration are weighing their options.
  
• 2009 in Review: Headline-Making Stories in the Biotech Industry
  Even though last year was marred by the economic crash, the life science sector showed significant progress.
  
• Asia-Pacific’s March toward a New Drug Development Paradigm
  Increasing investment, embracing new R&D models, and aligning regulatory agencies are key to the region’s success.
  
• Asia’s Emerging Markets Catching Up to the U.S. and Europe in Terms of Innovation
  Countries like China and Korea are growing to be more than just manufacturing hubs.
  
• For Some Emerging Companies, the Road to Growth Connects the U.S. and China
  While American firms are tapping China’s size and regulatory path, Chinese biotechs are going west for money and expertise.
  
• No Passage to India
  Private investment dearth clouds the future of the subcontinent’s fast-growing biopharma industry.
  
• China Dispatch: Clinical and Biobanking Activities
  Sharon Terry, president and CEO of the Genetic Alliance, weighs in from Beijing.
  
• China Dispatch: Rare Disease Collaborations
  Sharon Terry, president and CEO of the Genetic Alliance, brings us her latest from Shandong Province.
  
• China Dispatch: Rare Disease Epidemiology
  Sharon Terry, president and CEO of the Genetic Alliance, describes a conference she attended at the Shandong Academy of Medical Science.